Preview | Issue Date | Title | Author(s) |
| 2022 | Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia. | Lewis, A.C.; Pope, V.S.; Tea, M.N.; Li, M.; Nwosu, G.O.; Nguyen, T.M.; Wallington-Beddoe, C.T.; Moretti, P.A.; Anderson, D.; Creek, D.J.; Costabile, M.; Ali, S.R.; Thompson-Peach, C.A.; Dredge, B.K.; Bert, A.G.; Goodall, G.J.; Ekert, P.G.; Brown, A.L.; D'Andrea, R.J.; Robinson, N.; et al. |
| 2020 | Efficacy of combined CDK9/13ET inhibition in preclinical models of MLL-rearranged acute leukemia | McCalmont, H.; Li, K.L.; Jones, L.; Toubia, J.; Bray, S.C.; Casolari, D.A.; Mayoh, C.; Samaraweera, S.E.; Lewis, I.D.; Prinjha, R.K.; Smithers, N.; Wang, S.; Lock, R.B.; D'Andrea, R.J. |
| 2016 | Gaq signaling is required for the maintenance of MLL-AF9-induced acute myeloid leukemia | Lynch, J.R.; Yi, H.; Casolari, D.A.; Voli, F.; Gonzales-Aloy, E.; Fung, T.K.; Liu, B.; Brown, A.; Liu, T.; Haber, M.; Norris, M.D.; Lewis, I.D.; So, C.W.E.; D'Andrea, R.J.; Wang, J.Y. |
| 2012 | Global DNA methylation analysis identifies key pathway differences between poor (low OCT-1 activity) and standard risk CP-CML patients at diagnosis | Watkins, D.B.; Kok, C.H.; D'Andrea, R.J.; Hughes, T.P.; White, D.L.; 54th Annual Meeting and Exposition of the American Society of Hematology (ASH) (8 Dec 2012 - 11 Dec 2012 : Atlanta, GA) |
| 2015 | Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML | Forristal, C.E.; Brown, A.L.; Helwani, F.M.; Winkler, I.G.; Nowlan, B.; Barbier, V.; Powell, R.; Engler, G.A.; Diakiw, S.; Zannettino, A.C.W.; Martin, S.; Pattabiraman, D.; D'Andrea, R.J.; Lewis, I.D.; Levesque, J.P. |
| 2016 | Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies | Lewinsohn, M.; Brown, A.L.; Weinel, L.M.; Phung, C.; Rafidi, G.; Lee, M.K.; Schreiber, A.W.; Feng, J.; Babic, M.; Chong, C.E.; Lee, Y.; Yong, A.; Suthers, G.K.; Poplawski, N.; Altree, M.; Phillips, K.; Jaensch, L.; Fine, M.; D'Andrea, R.J.; Lewis, I.D.; et al. |
| 2021 | Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer | Singhal, D.; Hahn, C.N.; Feurstein, S.; Wee, L.Y.A.; Moma, L.; Kutyna, M.M.; Chhetri, R.; Eshraghi, L.; Schreiber, A.W.; Feng, J.; Wang, P.P.-S.; Babic, M.; Parker, W.T.; Gao, S.; Moore, S.; Das, S.; Thomas, D.; Pattnaik, S.; Brown, A.L.; D'Andrea, R.J.; et al. |
| 2012 | Unraveling the "known unknowns": lessons and reflections from the new directions in leukemia research 2012 conference | White, D.L.; Brown, A.L.; D'Andrea, R.J.; Rice, A.M. |